INHIBITORY ACTIONS OF ZENECA-ZD7288 ON WHOLE-CELL HYPERPOLARIZATION-ACTIVATED INWARD CURRENT (I(F)) IN GUINEA-PIG DISSOCIATED SINOATRIAL NODE CELLS
INHIBITORY ACTIONS OF ZENECA-ZD7288 ON WHOLE-CELL HYPERPOLARIZATION-ACTIVATED INWARD CURRENT (I(F)) IN GUINEA-PIG DISSOCIATED SINOATRIAL NODE CELLS
复制标题
DOI:
10.1111/j.1476-5381.1993.tb13815.x
复制
发表时间:
1993-09-01
影响因子:
7.3
通讯作者:
STURGESS, NC
中科院分区:
文献类型:
--
作者:
BOSMITH, RE;BRIGGS, I;STURGESS, NC
1 ZENECA ZD7288 (4-(N-ethyl-N-phenylamino)-1,2-dimethyl-6-(methylamino) pyrimidinium chloride) is a sinoatrial node (SAN) modulating agent which produces a selective slowing of the heart rate. Its effects have been studied in single, freshly dissociated guinea-pig SAN cells, by standard patch clamp procedures.2 Whole-cell inward currents were evoked by hyperpolarizing voltage clamp steps from a holding potential of -40 mV. ZD7288 inhibited the hyperpolarization activated cationic current (If) in a concentration-dependent manner. The 'selective bradycardic agents' alinidine and UL-FS 49 (zatebradine) both also inhibited I(f).3 The activation of I(f) was investigated by measuring tail current amplitudes at + 20 mV after hyperpolarizing steps to different potentials to activate the current. The reduction in I(f) resulted from both a shift in the I(f) current activation curve in the negative direction on the voltage axis, and also a reduction in the activation curve amplitude.4 ZD7288 did not affect the ion selectivity of the I(f) channel, since the tail current reversal potential was unchanged in the presence of the drug.5 With ZD7288 the inhibition of I(f) was not use-dependent, whereas UL-FS 49 displayed use-dependence in the block of the I(f) current.6 Whereas ZD7288 had no significant effect on the delayed rectifier current (I(k)) in these cells, both alinidine and UL-FS 49 significantly reduced I(k) at the same concentrations which reduced If.7 The data show that ZD7288 reduces I(f) by affecting the activation characteristics of the If current; this inhibition may account for this agent's selective bradycardic properties.